Angiodynamics (ANGO) Return on Invested Capital (2011 - 2025)

Angiodynamics (ANGO) has 15 years of Return on Invested Capital data on file, last reported at 0.04% in Q4 2025.

• Quarterly Return on Invested Capital rose 4.0% year-over-year to 0.04% in Q4 2025, while the trailing twelve-month figure through Nov 2025 was 0.04% (up 4.0% YoY) and the FY2024 annual result came in at 0.19%, down 15.0% from the prior year.
• Return on Invested Capital slipped to 0.04% in Q4 2025, from 0.03% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.0% in Q3 2023 to a low of 2.01% in Q1 2021.
• A 5-year average of 0.16% and a median of 0.02% in 2022 frame the typical range for Return on Invested Capital.
• Annual changes were most pronounced in 2021 — Return on Invested Capital slumped 201 bps — and 2025, when it rose 6 bps.
• Tracing ANGO's Return on Invested Capital over 5 years: stood at 2.01% in 2021, then soared by 99 bps to 0.01% in 2022, then surged by 77 bps to 0.0% in 2023, then plunged by 2710 bps to 0.09% in 2024, then jumped by 50 bps to 0.04% in 2025.
• The last three Return on Invested Capital figures came in at 0.04% (Q4 2025), 0.03% (Q3 2025), and 0.02% (Q2 2025), per Business Quant data.